Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Stealth Biotherapeutics Corp ADR (MITO)

Stealth Biotherapeutics Corp ADR (MITO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 81,192
  • Shares Outstanding, K 57,583
  • Annual Sales, $ 0 K
  • Annual Income, $ -57,460 K
  • 60-Month Beta 2.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MITO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year -0.02
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1200 +25.89%
on 08/23/21
1.5800 -10.76%
on 09/15/21
+0.1500 (+11.90%)
since 08/17/21
3-Month
1.1200 +25.89%
on 08/23/21
1.6200 -12.96%
on 07/02/21
-0.1100 (-7.24%)
since 06/17/21
52-Week
1.0600 +33.02%
on 04/21/21
2.5800 -45.35%
on 02/09/21
-0.1100 (-7.24%)
since 09/17/20

Most Recent Stories

More News
Stealth BioTherapeutics to Showcase Leadership in Retinal Mitochondrial Health with Clinical Updates at Ophthalmic Conferences

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.4100 (+1.44%)
Stealth BioTherapeutics to Present at Upcoming September Virtual Investor Conferences

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.4100 (+1.44%)
Stealth (MITO) Files NDA for Ultra-Rare Disease Candidate

Stealth BioTherapeutics (MITO) files a new drug application for elamipretide to the FDA for the treatment of Barth syndrome, an ultra-rare genetic condition.

VRTX : 188.30 (+0.64%)
CRVS : 5.32 (+135.40%)
SPRO : 19.15 (+0.52%)
MITO : 1.4100 (+1.44%)
Stealth BioTherapeutics Submits Elamipretide New Drug Application to FDA for Treatment of Barth Syndrome

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.4100 (+1.44%)
Stealth BioTherapeutics Strengthens IP Portfolio with Issuance of U.S. Patents Covering Elamipretide for Barth Syndrome

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.4100 (+1.44%)
Stealth BioTherapeutics to Present at H.C. Wainwright Ophthalmology Virtual Healthcare Conference

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.4100 (+1.44%)
Stealth BioTherapeutics Reports Second Quarter 2021 Financial Results And Recent Business Highlights

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.4100 (+1.44%)
Stealth BioTherapeutics to Report Second Quarter Financial Results on Thursday, August 5

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 1.4100 (+1.44%)
Stealth BioTherapeutics (MITO) Sees Hammer Chart Pattern: Time to Buy?

Stealth BioTherapeutics (MITO) has been struggling lately, but the selling pressure may be coming to an end soon.

MITO : 1.4100 (+1.44%)
Stealth BioTherapeutics Joins the Rare Disease Company Coalition

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving...

MITO : 1.4100 (+1.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Stealth BioTherapeutics Corp is a biopharmaceutical company. It is engaged in developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases. The company's product pipeline includes Elamipretide, SBT-20 and SBT-272 which...

See More

Key Turning Points

3rd Resistance Point 1.5867
2nd Resistance Point 1.5033
1st Resistance Point 1.4567
Last Price 1.4100
1st Support Level 1.3267
2nd Support Level 1.2433
3rd Support Level 1.1967

See More

52-Week High 2.5800
Fibonacci 61.8% 1.9994
Fibonacci 50% 1.8200
Fibonacci 38.2% 1.6406
Last Price 1.4100
52-Week Low 1.0600

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar